As part of Open Journals’ initiatives, we create website for scholarly open access journals.
If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at
https://ejournalplus.com or send us an email to info@ejournalplus.com
Efficacy of Cyclophosphamide and Mycophenolate Mofetil Based Induction Therapy in Egyptian Patients with Systemic Lupus Erythematosus-associated Nephritis
Background: Lupus nephritis (LN) is a serious manifestation of systemic lupus erythematosus. Induction immunosuppression can include high dose cyclophosphamide (NIH protocol), low dose cyclophosphamide (Euro-lupus protocol) or mycophenolate mofetil (MMF). We aimed to assess the efficacy and safety of the 3 induction regimens in Egyptian patients with LN.
(2021). Efficacy of Cyclophosphamide and Mycophenolate Mofetil Based Induction Therapy in Egyptian Patients with Systemic Lupus Erythematosus-associated Nephritis. European Journal of Molecular & Clinical Medicine, 8(2), 2672-2679.
Reham Abd- Elkhalek; Hala A Gaballah; Ola A Hussein; Marwa M El- Mosely; Shimaa M Abd El-Wahab. "Efficacy of Cyclophosphamide and Mycophenolate Mofetil Based Induction Therapy in Egyptian Patients with Systemic Lupus Erythematosus-associated Nephritis". European Journal of Molecular & Clinical Medicine, 8, 2, 2021, 2672-2679.
(2021). 'Efficacy of Cyclophosphamide and Mycophenolate Mofetil Based Induction Therapy in Egyptian Patients with Systemic Lupus Erythematosus-associated Nephritis', European Journal of Molecular & Clinical Medicine, 8(2), pp. 2672-2679.
Efficacy of Cyclophosphamide and Mycophenolate Mofetil Based Induction Therapy in Egyptian Patients with Systemic Lupus Erythematosus-associated Nephritis. European Journal of Molecular & Clinical Medicine, 2021; 8(2): 2672-2679.